Your session is about to expire
← Back to Search
Feasibility trial group for Autism Spectrum Disorder
Study Summary
This trial adapts an evidence-based occupational therapy intervention to a telehealth delivery model to address the sensory motor symptoms of ASD and measure outcomes in daily activities.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Group 1: Feasibility trial group
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this research study open to seniors aged 65 years and older?
"As laid out in the study's criteria, patients between 4 and 12 years old are eligible to participate."
Who is best suited for participation in this clinical experiment?
"Applicants to this clinical trial should have a diagnosed instance of autism spectrum disorder and must be between the ages 4-12. As such, only 10 participants are being accepted."
How many participants is this clinical trial enrolling?
"Affirmative. According to the details available on clinicaltrials.gov, this medical study is still recruiting patients with a start date of March 1st 2023 and latest edit made June 1st 2023. This trial requires 10 participants across one research centre."
Is recruitment currently open for this clinical experiment?
"According to the clinicaltrials.gov, this research is presently in progress with recruitment underway. The trial was initially made public on March 1st 2023 and it has been revised most recently on June 1st 2023."
Share this study with friends
Copy Link
Messenger